【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Iressa
04.1.2 Abraxane
04.1.3 Alimta
04.1.4 Gemzar
04.1.5 Xalkori
04.1.6 Avastin
04.1.7 Tarceva
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Economic Burden
07.3 Classification of Lung Cancer
07.4 Diagnosis
07.5 Small Cell Lung Cancer
07.5.1 Rate of Incidence and Prevalence
07.5.2 Staging
07.5.3 Management
07.6 Non-small Cell Lung Cancer
07.6.1 Rate of Incidence and Prevalence
07.6.2 Staging
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Type
09.1 Global Non-small Cell Lung Cancer Therapeutics Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Molecule Type
09.1.3 Market Segmentation by Routes of Administration
09.2 Global Small Cell Lung Cancer Therapeutics Market
09.2.1 Market Size and Forecast
10.Market Segmentation by Molecule Type
10.1 Biologics
10.2 Small Molecules
11.Market Segmentation by Route of Administration
11.1 Oral
11.2 Parenteral
12.Geographical Segmentation
12.1 Global Non-Small-Cell Lung Cancer Market
12.2 Global Small Cell Lung Cancer Market
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 AstraZeneca
20.2.2 Celgene
20.2.3 Eli Lilly
20.2.4 F. Hoffmann-La Roche
20.2.5 Pfizer
20.3 Other and Future Prominent Vendors
21.Pipeline Portfolio
21.1.1 Non-small Cell Lung Cancer
21.1.2 Small Cell Lung Cancer
22.Key Vendor Analysis
22.1 AstraZeneca
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Business Strategy
22.1.5 Revenue by Business Segmentation
22.1.6 Revenue Comparison 2011-2013
22.1.7 Sales Revenue by Geographical Segmentation
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 Celgene
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Strategy
22.2.4 Business Segmentation by Revenue
22.2.5 Sales by Geography
22.2.6 Key Information
22.2.7 SWOT Analysis
22.3 Eli Lilly
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue
22.3.4 Sales by Geography
22.3.5 Business Strategy
22.3.6 Key Information
22.3.7 SWOT Analysis
22.4 F. Hoffmann-La Roche Ltd.
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Information
22.4.8 SWOT Analysis
22.5 Pfizer
22.5.1 Key Facts
22.5.2 Business Overview
22.5.3 Business Segmentation by Revenue 2013
22.5.4 Business Segmentation by Revenue 2012 and 2013
22.5.5 Geographical Segmentation by Revenue
22.5.6 Business Strategy
22.5.7 Key Developments
22.5.8 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Incidence Data of Lung Cancer pertaining to WHO Regions
Exhibit 3: Classification of Lung Cancer Types
Exhibit 4: Diagnosis of Lung Cancer in Patients
Exhibit 5: Staging of Small Cell Lung Cancer
Exhibit 6: Stepwise Diagrammatic Representation of the Management of Small Cell Lung Cancer According to the ESMO Guidelines
Exhibit 7: Types of Non-small Cell Lung Cancer
Exhibit 8: Percentage of Gene Mutations in Non-small Cell Lung Cancer
Exhibit 9: Staging of Non-small Cell Lung Cancer
Exhibit 10: Global Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 11: Global Lung Cancer Therapeutics Market Segmentation by Disease Type
Exhibit 12: Global Lung Cancer Therapeutics Market Segmentation by Disease Type 2014
Exhibit 13: YoY Revenue Comparison of Global Non-small Cell Lung Cancer Therapeutics market and Global Small Cell Lung Cancer Therapeutics market 2014-2019 (US$ million)
Exhibit 14: Global Non-small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 15: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type
Exhibit 16: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type 2014
Exhibit 17: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration
Exhibit 18: Global Non-Small-Cell Lung Cancer Market Segmentation by Routes of Administration 2014
Exhibit 19: Global Small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 20: Global Lung Cancer Therapeutics Market Segmentation by Molecule Type
Exhibit 21: Global Lung Cancer Therapeutics Market Segmentation by Molecule Type 2014
Exhibit 22: Global Lung Cancer Therapeutics Market Segmentation by Route of Administration
Exhibit 23: Global Lung Cancer Therapeutics Market Segmentation by Route of Administration 2014
Exhibit 24: Global Lung Cancer Therapeutics Market by Geographical Segmentation 2014
Exhibit 25: Global Non-small Cell Lung Cancer Market by Geographical Segmentation 2014
Exhibit 26: Global Small Cell Lung Cancer Market by Geographical Segmentation 2014
Exhibit 27: Buying Criteria of Global Lung Cancer Therapeutics Market 2014
Exhibit 28: Drivers of the Global Lung Cancer Therapeutics Market
Exhibit 29: Challenges of the Global Lung Cancer Therapeutics Market
Exhibit 30: Trends of the Global Lung Cancer Therapeutics Market
Exhibit 31: Global Lung Cancer Therapeutics Market by Vendor Segmentation 2014
Exhibit 32: Global Non-Small-Cell Lung Cancer Market by Market Share Analysis 2014
Exhibit 33: Sales Comparison of Major Drugs 2010-2013 (US$ million)
Exhibit 34: Sales of Iressa 2006-2013 (US$ million)
Exhibit 35: Sales of Iressa in Western Europe 2009-2013 (US$ million)
Exhibit 36: Sales of Iressa in Established ROW 2009-2013 (US$ million)
Exhibit 37: Sales of Iressa in Emerging Markets 2009-2013 (US$ million)
Exhibit 38: Region-wise Sales of Iressa 2009-2011 (US$ million)
Exhibit 39: Sales of Abraxane 2010-2013 (US$ million)
Exhibit 40: Sales of Alimta in US 2004-2013 (US$ million)
Exhibit 41: Sales of Alimta Outside US 2004-2013 (US$ million)
Exhibit 42: Total Sales of Alimta 2004-2013 (US$ million)
Exhibit 43: Region-wise Sales of Alimta 2004-2013 (US$ million)
Exhibit 44: Sales of Gemzar in US 2003-2011 (US$ million)
Exhibit 45: Sales of Gemzar Outside US 2003-2011 (US$ million)
Exhibit 46: Total Sales of Gemzar 2003-2011 (US$ million)
Exhibit 47: Region-wise Sales Gemzar 2003-2011 (US$ million)
Exhibit 48: Sales of Avastin and Tarceva 2005-2013 (US$ million)
Exhibit 49: Sales of Avastin 2005-2013 (US$ million)
Exhibit 50: Sales of Tarceva 2005-2013 (US$ million)
Exhibit 51: Sales Forecast for Xalkori 2013-2018 (US$ million)
Exhibit 52: Phase III Pipeline Portfolio of Global Lung Cancer Therapeutics Market by Disease Type 2014
Exhibit 53: Late-stage Pipeline Molecules for Non-small Cell Lung Cancer
Exhibit 54: Late-stage Pipeline Molecules for Small Cell Lung Cancer
Exhibit 55: Study Count of Small Cell Lung Cancer Clinical Trials by Geography
Exhibit 56: Study Count of Non-small Cell Lung Cancer Clinical Trials by Geography
Exhibit 57: AstraZeneca: Business Segmentation
Exhibit 58: AstraZeneca: Revenue by Business Segmentation 2013
Exhibit 59: AstraZeneca: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 60: AstraZeneca: Sales Revenue by Geographical Segmentation 2013
Exhibit 61: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 62: Celgene: Sales by Geography 2013
Exhibit 63: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 64: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 65: Eli Lilly: Sales by Geography 2013
Exhibit 66: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 70: Pfizer: Business Segmentation by Revenue 2013
Exhibit 71: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 72: Pfizer: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：肺がん治療薬の世界市場：非小細胞肺がん、小細胞肺がん■ 英文：Global Lung Cancer Therapeutics Market 2015-2019
■ 発行日：2014年11月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4668
■ 調査対象地域：グローバル
- マネージド型セキュリティサービスの世界市場2016-2020About Managed Security Services Managed security services are the services provided by an outsourced managed security service provider to maintain information security and network security. This service is provided either on the client's premises or it is outsourced to a company that specializes in networking and information system security. Managed security service providers (MSSPs) offer managed …
- 硬質プラスチック包装の世界市場2015-2025The surging economies in the developing nations, the expansion of the on-the-go lifestyle and the ageing population are significantly increasing demand for more convenient, easy-to-carry, light, safe and functional packaging, without comprising on the barrier properties and cost effectiveness. This has given rise to a boom in the rigid plastic packaging market as rigid plastic is a light, malleabl …
- アポトーシスアッセイの世界市場予測（～2023年）“The global apoptosis assays market is projected to grow at a CAGR of 10.5%”The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%. The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are …
- グラフ分析の世界市場予測：コンポーネント別、組織規模別、用途別、業種別The global graph analytics market size to grow at a CAGR of 34.0% during the forecast periodThe graph analytics market size is projected to grow from USD 584 million in 2019 to USD 2,522 million by 2024, at a Compound Annual Growth Rate (CAGR) of 34.0% during the forecast period. The graph analytics market is driven by the growing demand to analyze low-latency queries, advancements in graph analyt …
- 在宅医療ソフトウェアのグローバル市場（～2018）Homecare-EMR, electronic point-of-care documentation, and homecare-CRM are lucrative markets for investors Several initiatives and healthcare reforms have been developed in order to support the adoption and implementation of homecare software, especially hospital readmission program by Affordable Care Act, and new health plan budget approved by Obama’s care where reimbursement value is cut down by …
- RFパワー半導体の世界市場：RFパワーアンプ、RFパッシブ、RFスイッチ、RFデュプレクサーAccording to the MarketsandMarkets forecast, the RF power semiconductor market size, in terms of value, is expected to grow from USD 10.57 Billion in 2015 to USD 31.26 Billion by 2022, at a CAGR of 15.4% between 2016 and 2022. The rapid growth of the smartphone market, increased use of LTE, and increased use of RF power for lighting applications are factors that help drive the RF power semiconduct …
- マイクロ波無線の世界市場2016-2020About Microwave Radios Microwave radios work on the underlying principle of microwave transmission. They transmit or exchange information between two devices using electromagnetic waves, having a wavelength ranging from 30 cm to 0.1 cm with radio spectrum of 1 GHz to 300 GHz. Microwaves follow point-to-point communication and can be easily directed by small-sized antennas, which point these narrow …
- 親水性皮膜の世界市場分析：基盤別（ポリマー、ガラス、金属、ナノ粒子）、用途別（航空宇宙、自動車、海洋、医療機器、光学機器）、地域別（北アメリカ、ヨーロッパ、APAC、その他の世界）、セグメント予測、2014-2025The global hydrophilic coatings market size is projected to reach USD 14.74 billion by 2025, according to a new report by Grand View Research, Inc. The demand for the product is expected to grow significantly over the forecast period, driven by the rising application scope in industries including automotive, medical, optical and aerospace. Rising development of medical infrastructure in developing …
- シリコンフォトニクスの世界市場2016-2020About Silicon Photonics Silicon photonics is a novel technology that aims to develop silicon-based optical devices. Due to the availability of large established silicon fabrication units and the relatively low cost and high abundance of this material, there are high hopes in the semiconductor industry for this technology. Technavio’s analysts forecast the global silicon photonics market to grow at …
- チューブ包装パッケージの世界市場：積層チューブ、アルミニウムチューブ、プラスチックチューブThe tube packaging market includes all the types of tubes such as squeeze tubes, twist tubes, and other tubes. The tube packaging market has varied applications, such as cosmetics & oral care, food & beverages, pharmaceuticals, consumer goods, and others. Tubes possess properties such as excellent barrier properties, convenient packaging, which fuel the growth of the tube packaging market. The mar …
- Saudi ArabiaのNitric Acid, Sulphonitric Acids市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for nitric acid, sulphonitric acids. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on nitric acid, sulphonitric acids export/import operations in Saudi Arab …
- 教育用装置の世界市場：パソコン、タブレット、ディスプレイ、電子黒板、スタイラスペン、ワイヤレススレート、ウェアラブル端末、プロジェクター、サウンド装置About the Global Education Hardware Market Over the years, there has been a significant increase in the adoption of technology in the education sector globally. With an increase in investment by educational institutions to build IT infrastructure, there has been a noteworthy influence on the way education is imparted. As a result, the traditional classroom structure is gradually being replaced by …
- 世界のオンラインビデオプラットフォーム市場動向（2012-2016）TechNavio's analysts forecast the Global Online Video Platforms market to grow at a CAGR of 25.64 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high growth in the online video audience. The Global Online Video Platforms market has also been witnessing the high demand for standardization. However, the security issues could pose a challenge to th …
- 微生物検査の世界市場2017-2021ABSTRACTAbout Microbiology Testing Microbiological tests are conducted to study the various types of microbes such as bacterial, yeast, fungi, and viruses and their effects on an individual. Microbial testing products provide a wide array of experimental approaches for the diagnosis of infections. Microbiological testing helps detect the presence of pathogenic microorganisms and their metabolites …
- 世界の小売り業界におけるデジタルトランスフォーメーション市場：技術別、地域別Global Digital Transformation Market in the Retail Sector Market: About this market Technavio’s digital transformation market in the retail sector analysis considers sales from IoT, cloud computing, big data, AI, and AR/VR technologies. Our study also finds the sales of milk chocolates in APAC, Europe, MEA, North America, and South America. In 2019, the IoT segment had a significant market share, …
